DLK1 and neoplasm: Consistently, IHC analysis at early timepoints (days 6 and 9) identified a significantly higher Dlk1+ fraction of hepatocytes in the tumour-prone PGK-NRASG12V or UBC-NRASG12V mice than in CAGGS-NRASG12V mice (Extended Data Fig. 7d).